During the past decade, Nuovo Ospedale di Prato conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nuovo Ospedale di Prato" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Italian Sarcoma Group" with 5 trials sponsored, "National Cancer Institute, Naples" with 3 trials sponsored, "Ospedale Misericordia e Dolce" with 2 trials sponsored and "Biotronik SE & Co. KG" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nuovo Ospedale di Prato" #1 collaborator was "PharmaMar" with 4 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Averion International Corporation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Nuovo Ospedale di Prato" are "Acute Kidney Injury" (3 trials), "Breast Cancer" (3 trials), "Advanced Non-Small Cell Lung Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Advanced Soft Tissue Sarcoma" (1 trials). Many other conditions were trialed in "Nuovo Ospedale di Prato" in a lesser frequency.

Most popular intervention types in "Nuovo Ospedale di Prato" are "Drug" (26 trials), "Device" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (4 trials), "Trabectedin" (4 trials), "Cyclophosphamide" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nuovo Ospedale di Prato" are 28 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Nuovo Ospedale di Prato". undefined are not yet recruiting, 8 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Nuovo Ospedale di Prato, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nuovo Ospedale di Prato, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".